Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Atherosclerosis. 2013 Oct 11;231(2):315–322. doi: 10.1016/j.atherosclerosis.2013.09.027

Table 2.

Adjusted* Odds Ratio (and 95% confidence interval) from logistic and GEE regression models for quartiles of oxLDL-IC in relation to elevated internal carotid IMT and IMT progression.

6 Year ICA IMT 12 Year ICA IMT IMT Progression Year 1 to 12 Elevated ICA IMT
Model 1*
 Lowest Quartile 1.00 1.00 1.00 1.00
 Quartile 2 1.65 (0.74-3.66) 1.35 (0.57-3.19) 1.66 (0.70-3.95) 1.94 (0.91-4.14)
 Quartile 3 1.53 (0.67-3.49) 2.09 (0.84-5.24) 1.89 (0.75-4.78) 2.13 (0.99-4.57)
 Quartile 4 2.72 (1.24-5.97) 3.99 (1.69-9.40) 4.93 (2.08-11.7) 4.78 (2.30-9.91)
 ROC AUC 0.748 0.813 0.797 ---
Model 2*
 Lowest Quartile 1.00 1.00 1.00 1.00
 Quartile 2 1.18 (0.52-2.67) 1.10 (0.44-2.74) 1.55 (0.59-4.03) 1.32 (0.61-2.89)
 Quartile 3 1.13 (0.49-2.61) 1.89 (0.74-4.87) 1.94 (0.74-5.07) 1.66 (0.78-3.55)
 Quartile 4 1.79 (0.78-4.12) 3.52 (1.36-9.10) 5.13 (1.98-13.3) 2.98 (1.34-6.62)
 ROC AUC 0.778 0.849 0.833 ---
Model 3*
 Lowest Quartile 1.00 1.00 1.00 1.00
 Quartile 2 1.69 (0.71-4.02) 1.05 (0.38-2.90) 1.47 (0.51-4.25) 1.31 (0.56-3.05)
 Quartile 3 1.52 (0.62-3.75) 1.71 (0.60-4.85) 2.06 (0.72-5.88) 1.73 (0.74-4.03)
 Quartile 4 3.04 (1.24-7.49) 4.18 (1.48-11.8) 5.89 (2.12-16.4) 3.66 (1.52-8.79)
 ROC AUC 0.785 0.862 0.845 ---
*

Model 1 is adjusted for age, gender, primary retinopathy cohort, diabetes duration, natural log of AER, IMT reader ID and closeout HbA1c; Model 2 is additionally adjusted for LDL-C, HDL-C, SBP at DCCT closeout; smoking status at enrollment; ACE/ARB use and statin use through EDIC year 12 and study mean HbA1c rather than closeout HbA1c; Model 3 is adjusted for LDL and HDL mean particle concentration rather than LDL and HDL cholesterol levels.